Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
C

CL

NYSE

COLGATE PALMOLIVE CO

Latest disclosureOctober 2, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 6 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 78

Limited filing history
All78Buying0Selling6Other72
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

72 of 78 trades · April 1, 2026 – October 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Award disclosed

Lorrie M. Norrington

Director

Common Stock

Value context
$26.23K
Reported price
$87.42 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Award disclosed

Brian Newman

Director

Common Stock

Value context
$18.71K
Reported price
$87.42 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Award disclosed

John P. Bilbrey

Director

Common Stock

Value context
$23.69K
Reported price
$87.42 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Award disclosed

Noel R. Wallace

Chairman, President & CEO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Noel R. Wallace

Chairman, President & CEO

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Shane Grant

COO, Americas

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Shane Grant

COO, Americas

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Panagiotis Tsourapas

COO, CD, EMEA, APac, Skin

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Panagiotis Tsourapas

COO, CD, EMEA, APac, Skin

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Stanley J. Sutula III

Chief Financial Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Stanley J. Sutula III

Chief Financial Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

John Hazlin

Chief Growth Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

John Hazlin

Chief Growth Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Sally Massey

Chief People Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Sally Massey

Chief People Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Betsy Fishbone

CLO and Secretary

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Betsy Fishbone

CLO and Secretary

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Gregory Malcolm

EVP and Controller

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Award disclosed

Gregory Malcolm

EVP and Controller

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 16, 2026Filed September 18, 2026SEC filing
Tax or exercise withholding

Noel R. Wallace

Chairman, President & CEO

Common Stock

Value context
$353.36K
Reported price
$86.80 / share
Traded September 11, 2026Filed September 15, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorCommon StockGrant or award300$87.42 / share$26.23KOct 1Filed Oct 2 · 1d laterSEC filing
DirectorCommon StockGrant or award214$87.42 / share$18.71KOct 1Filed Oct 2 · 1d laterSEC filing
DirectorCommon StockGrant or award271$87.42 / share$23.69KOct 1Filed Oct 2 · 1d laterSEC filing
Chairman, President & CEOCommon StockGrant or award29,649Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chairman, President & CEOStock Option (Right to Buy)Grant or awardDerivative units205,197Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
COO, AmericasCommon StockGrant or award7,355Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
COO, AmericasStock Option (Right to Buy)Grant or awardDerivative units50,902Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
COO, CD, EMEA, APac, SkinCommon StockGrant or award4,597Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
COO, CD, EMEA, APac, SkinStock Option (Right to Buy)Grant or awardDerivative units31,814Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chief Financial OfficerCommon StockGrant or award8,045Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chief Financial OfficerStock Option (Right to Buy)Grant or awardDerivative units55,674Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chief Growth OfficerCommon StockGrant or award3,908Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chief Growth OfficerStock Option (Right to Buy)Grant or awardDerivative units27,042Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chief People OfficerCommon StockGrant or award3,333Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chief People OfficerStock Option (Right to Buy)Grant or awardDerivative units23,065Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
CLO and SecretaryCommon StockGrant or award2,207Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
CLO and SecretaryStock Option (Right to Buy)Grant or awardDerivative units15,271Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
EVP and ControllerCommon StockGrant or award1,081Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
EVP and ControllerStock Option (Right to Buy)Grant or awardDerivative units7,477Award · no purchase priceNon-cash awardSep 16Filed Sep 18 · 2d laterSEC filing
Chairman, President & CEOCommon StockExercise-price or tax withholding4,071$86.80 / share$353.36KSep 11Filed Sep 15 · 4d laterSEC filing

Showing the latest 20 of 72 trades. Show all 72 trades

Congress transactions 10

All Congress filings
Partial sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a partial sale for a joint account.

Kevin Hern official portraitKevin HernReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 2, 2026
Filed September 25, 2026 · 23d laterOriginal report
Sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a sale for the member.

Kevin Hern official portraitKevin HernReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 31, 2026
Filed September 25, 2026 · 25d laterOriginal report
Partial sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a partial sale for the member.

Kevin Hern official portraitKevin HernReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 27, 2026
Filed September 25, 2026 · 29d laterOriginal report
Sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a sale for a joint account.

Kevin Hern official portraitKevin HernReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 19, 2026
Filed September 1, 2026 · 13d laterOriginal report
Sale disclosedAmended report

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 23, 2025
Filed August 5, 2026 · 316d laterOriginal report
Purchase disclosedAmended report

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a purchase for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 23, 2025
Filed August 5, 2026 · 316d laterOriginal report
Sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 11, 2025
Filed October 22, 2025 · 41d laterOriginal report
Sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a sale for the member.

Rick Larsen official portraitRick LarsenReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 6, 2025
Filed October 16, 2025 · 10d laterOriginal report
Sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a sale for the member.

Tim Moore official portraitTim MooreReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 10, 2025
Filed October 10, 2025 · 30d laterOriginal report
Sale disclosed

Colgate-Palmolive Company Common Stock (CL) · Stock

The filing reports a sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 25, 2025
Filed October 7, 2025 · 12d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000021665
Latest public acceptance
Oct 2, 2026, 08:06 PM UTC
Score calculated
Oct 7, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.